Search Results 101-110 of 16554 for retroperitoneal liposarcoma
The objective of this study is to leverage novel molecular assays to identify predictive and prognostic biomarkers for sarcoma. Participation eligibility.
CMB305 is a novel approach designed to stimulate the body's immune system to fight the spread and growth of cancer in patients whose tumors express the NY-ESO-1 ...
... Sarcoma, Retroperitoneal sarcoma, Liposarcoma, Stage 4 colorectal cancer, Liver tumor. Show more areas of focus for Cornelius A. Thiels, D.O., M.B.A. ...
The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...
This study is being done to collect clinical data and store samples of your blood and tissue for current and future research studies on sarcoma. Participation ...
... sarcoma that have not received taxane drugs, and how well nivolumab and cabozantinib work in treating taxane pretreated patients with soft tissue sarcoma.
... Sarcoma, Enlarged spleen, Retroperitoneal sarcoma, Biliary obstruction, Gallbladder polyp, Hilar cholangiocarcinoma, Peritoneal cancer, Appendix cancer ...
... sarcoma. The study also traced tumor growth to chromoplexy: a complex chromosomal rearrangement that causes genes to scramble, break DNA strands and then ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.